Nightingale Health, a Finland-based medical technology firm, has extended its partnership with Terveystalo, Finland’s largest private healthcare provider, to broaden the use of its blood analysis across all customer segments. 

The technology evaluates multiple chronic disease risks from a single sample and has already been incorporated into occupational health checks for over 200,000 individuals.

Terveystalo’s preventive health care and obesity care medical director, Ilse Rauhaniemi, said, “Preventive health is at the core of Terveystalo’s operations. Collaboration with an innovative technology company has provided our customers with unique insight into their own health and health promotion.” She added that the updated agreement strengthens Terveystalo’s preventive services and promotes scalable, cost-effective approaches in clinical practice.

The integration allows Terveystalo to offer routine health assessments with advanced predictive analytics. Nightingale Health founder and CEO Teemu Suna highlighted that the partnership enables proactive health to become a standard element of healthcare delivery. He stated, “Our work with Terveystalo has shown that prevention can be integrated into daily care for hundreds of thousands of people. Expanding this partnership allows us to extend that impact across all customers of Terveystalo.”

Terveystalo operates around 360 clinics and 17 hospitals across Finland and provides occupational health services at approximately 140 sites in Sweden. The organisation serves private, corporate, and public sector clients, offering primary care, digital health services, and well-being support. Nightingale Health maintains a global presence with subsidiaries in the US, UK, Singapore, and Japan.

Learn how Terveystalo and Nightingale are shaping preventive health in occupational and clinical settings in the complete story.